摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-吗啉基甲基)苯硼酸频哪酯 | 876316-33-5

中文名称
2-(4-吗啉基甲基)苯硼酸频哪酯
中文别名
4-[2-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)苄基]吗啉
英文名称
4-[[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]morpholine
英文别名
4-[2-(4,4,5,5-tetramethyl-[1,3,2]dioxaboraol-2-yl)-benzyl]-morpholine;4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
2-(4-吗啉基甲基)苯硼酸频哪酯化学式
CAS
876316-33-5
化学式
C17H26BNO3
mdl
——
分子量
303.209
InChiKey
WCNXVDLZTGODQW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    120 °C
  • 密度:
    1.08±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.82
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    30.9
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    C
  • 海关编码:
    2934999090
  • 危险性防范说明:
    P233,P260,P261,P264,P270,P271,P280,P301+P312,P302+P352,P304,P304+P340,P305+P351+P338,P312,P321,P330,P332+P313,P337+P313,P340,P362,P403,P403+P233,P405,P501
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:7ddfe2c880b31f38845a3d7b38e5f97a
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-(Morpholinomethyl)phenylboronic acid, pinacol ester
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(Morpholinomethyl)phenylboronic acid, pinacol ester
CAS number: 876316-33-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C17H26BNO3
Molecular weight: 303.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴苯甲醚2-(4-吗啉基甲基)苯硼酸频哪酯四(三苯基膦)钯 、 sodium carbonate 作用下, 以 乙醇甲苯 为溶剂, 反应 0.17h, 以63%的产率得到4-((4'-methoxybiphenyl-2-yl)methyl)morpholine
    参考文献:
    名称:
    Microwave-Mediated Suzuki–Miyaura Cross-Couplings of Thioether- and ortho-Substituted Methylphenylboronic Acid Esters
    摘要:
    Hiterto unsuccessful cross-couplings of ortho-substituted or thioether-substituted methylphenylboronates have now been achieved, under microwave conditions, enabling the synthesis of a library of novel biaryls. Tetrakis(triphenylphosphine) palladium and various bases, for example, sodium carbonate or cesium fluoride, were found to mediate the crucial C-C bond-forming cross-coupling reaction.
    DOI:
    10.1055/s-0032-1317205
  • 作为产物:
    描述:
    溴甲苯 在 (1,5-cyclooctadiene)(methoxy)iridium(I) dimer 、 potassium carbonate 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 生成 2-(4-吗啉基甲基)苯硼酸频哪酯
    参考文献:
    名称:
    芳烃和药物的 Ir 催化无配体定向 C-H 硼化:详细的机理理解
    摘要:
    一种 Ir 催化的芳烃(例如 2-苯氧基吡啶、2-苯胺基吡啶、苄胺、苄基哌嗪、苄基吗啉、苄基吡咯烷、苄基哌啶、苄基氮杂环己烷、α-氨基酸衍生物、氨基苯基乙烷衍生物和其他重要支架)的无配体邻位硼化的有效方法) 并开发了药物。正如通过使用动力学同位素研究和 DFT 计算进行的详细机理研究所揭示的那样,该反应通过一个有趣的机理途径进行。发现催化循环涉及 Ir-硼基络合物的中间体,其中底物 C-H 活化是转换决定步骤,有趣的是没有任何明显的初级 KIE。该方法显示了广泛的底物范围和官能团耐受性。使用这种开发的策略实现了各种重要分子和药物的许多后期硼化。硼化化合物进一步转化为更有价值的官能团。此外,利用单硼化化合物的 B-N 分子内相互作用的优势,开发了一种操作简单的方法,用于选择性二硼化 2-苯氧基吡啶和许多官能化芳烃。此外,还展示了从硼化产物中去除吡啶基导向基团以实现邻硼化苯酚以及用于制备 1,2-二硼化苯的
    DOI:
    10.1021/acs.joc.2c00046
点击查看最新优质反应信息

文献信息

  • Chemical Compounds 637
    申请人:Bonnert Roger Victor
    公开号:US20090124596A1
    公开(公告)日:2009-05-14
    The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    本发明提供了一种公式(I)的化合物:其中变量在此定义;提供制备这种化合物的过程;以及将这种化合物用于治疗PDE4介导的疾病状态。
  • Microwave-Mediated Synthesis of an Arylboronate Library
    作者:John Spencer、Christine B. Baltus、Hiren Patel、Neil J. Press、Samantha K. Callear、Louise Male、Simon J. Coles
    DOI:10.1021/co100011g
    日期:2011.1.10
    A series of arylboronates has been synthesized from the reaction of 2-(2-, (3-, or (4-(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 11-3) respectively with a range of N-, S-, and O-nucleophiles, using microwave-mediated chemistry. For the synthesis of N- and S-substituted boronates, a supported base, PS-NMM, was employed, and many reactions were complete within 15 min. With O-nucleophiles, a mixture of tetrabutylammonium bromide, potassium carbonate, and sodium hydroxide was employed. The resulting aminomethyl, mercaptomethyl, or alkoxy-/phenoxymethyl-arylboronates were subjected to microwave-mediated Suzuki Miyaura coupling reactions to afford a range of biaryls in moderate to good yields. The X-ray structures of five boronates were determined.
  • Ir-Catalyzed Ligand-Free Directed C–H Borylation of Arenes and Pharmaceuticals: Detailed Mechanistic Understanding
    作者:Mirja Md Mahamudul Hassan、Biplab Mondal、Sukriti Singh、Chabush Haldar、Jagriti Chaturvedi、Ranjana Bisht、Raghavan B. Sunoj、Buddhadeb Chattopadhyay
    DOI:10.1021/acs.joc.2c00046
    日期:2022.3.18
    intermediacy of an Ir-boryl complex where the substrate C–H activation is the turnover determining step, intriguingly without any appreciable primary KIE. The method displays a broad range of substrate scope and functional group tolerance. Numerous late-stage borylation of various important molecules and drugs were achieved using this developed strategy. The borylated compounds were further converted into
    一种 Ir 催化的芳烃(例如 2-苯氧基吡啶、2-苯胺基吡啶、苄胺、苄基哌嗪、苄基吗啉、苄基吡咯烷、苄基哌啶、苄基氮杂环己烷、α-氨基酸衍生物、氨基苯基乙烷衍生物和其他重要支架)的无配体邻位硼化的有效方法) 并开发了药物。正如通过使用动力学同位素研究和 DFT 计算进行的详细机理研究所揭示的那样,该反应通过一个有趣的机理途径进行。发现催化循环涉及 Ir-硼基络合物的中间体,其中底物 C-H 活化是转换决定步骤,有趣的是没有任何明显的初级 KIE。该方法显示了广泛的底物范围和官能团耐受性。使用这种开发的策略实现了各种重要分子和药物的许多后期硼化。硼化化合物进一步转化为更有价值的官能团。此外,利用单硼化化合物的 B-N 分子内相互作用的优势,开发了一种操作简单的方法,用于选择性二硼化 2-苯氧基吡啶和许多官能化芳烃。此外,还展示了从硼化产物中去除吡啶基导向基团以实现邻硼化苯酚以及用于制备 1,2-二硼化苯的
  • Microwave-Mediated Suzuki–Miyaura Cross-Couplings of Thioether- and ortho-Substituted Methylphenylboronic Acid Esters
    作者:John Spencer、Christine Baltus、Neil Press
    DOI:10.1055/s-0032-1317205
    日期:——
    Hiterto unsuccessful cross-couplings of ortho-substituted or thioether-substituted methylphenylboronates have now been achieved, under microwave conditions, enabling the synthesis of a library of novel biaryls. Tetrakis(triphenylphosphine) palladium and various bases, for example, sodium carbonate or cesium fluoride, were found to mediate the crucial C-C bond-forming cross-coupling reaction.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐